ORAL FORMULATIONS FOR ENTERIC DISORDERS AND/OR REHYDRATION
    10.
    发明申请
    ORAL FORMULATIONS FOR ENTERIC DISORDERS AND/OR REHYDRATION 审中-公开
    输入性疾病和/或复发的口服制剂

    公开(公告)号:US20100003235A1

    公开(公告)日:2010-01-07

    申请号:US12088631

    申请日:2006-09-28

    摘要: The present invention relates, generally, to oral formulations including one or more recombinantly-produced human milk proteins. The formulations of the present invention may be used to prevent the onset of diarrhea in patients who have been or will be exposed to one or more agents known to cause diarrhea, and to prevent the recurrence of diarrhea in a patient recovering therefrom. The formulations may also be used in the treatment of inflammatory bowel disease, including Crohn's disease and ulcerative colitis. The formulations may also be beneficially administered in accordance with methods for promoting the development of healthy intestinal flora in a human patient.

    摘要翻译: 本发明一般涉及含有一种或多种重组产生的人乳蛋白质的口服制剂。 本发明的制剂可以用于预防已经或将要暴露于已知或将暴露于一种或多种已知引起腹泻的药剂的患者中的腹泻发作,并且防止在其中恢复的患者中腹泻复发。 制剂也可用于治疗炎性肠病,包括克罗恩病和溃疡性结肠炎。 根据用于促进人类患者中健康肠道菌群发育的方法,也可有利地施用制剂。